Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NeuroPace IncNPCE · Entity 5459 | CHIEF FINANCIAL OFFICER | June 03, 2025 | June 06, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NeuroPace Inc
Report date June 03, 2025 · Filed June 06, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 131,613 |
Reported balance
After 2025-06-03 transaction · row 1
1 source rowRow 1 · 2025-06-03 · Tax withholding · Disposed 1,337 · Balance 131,613 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2025 Filed Jun 6, 2025 19:15 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 1,337 | $13.54 | $18,102.98 |
DisclosureSEC source: 0001415889-25-016078 · form4-06062025_070603.xml · nonDerivative · entry 1 Kuhn Rebecca · CIK 0001855659 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,613 Read SEC document |
| May 27, 2025 Filed May 29, 2025 19:10 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 357 | $12.66 | $4,519.62 |
DisclosureSEC source: 0001415889-25-014932 · form4-05292025_070505.xml · nonDerivative · entry 1 Kuhn Rebecca · CIK 0001855659 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,950 Read SEC document |
| May 20, 2025 Filed May 21, 2025 19:15 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 3,051 | $17.99 | $54,887.49 |
DisclosureSEC source: 0001415889-25-014014 · form4-05212025_070503.xml · nonDerivative · entry 1 Kuhn Rebecca · CIK 0001855659 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,307 Read SEC document |
| April 22, 2025 Filed Apr 23, 2025 19:45 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 237 | $10.94 | $2,592.78 |
DisclosureSEC source: 0001415889-25-011242 · form4-04232025_110441.xml · nonDerivative · entry 1 Kuhn Rebecca · CIK 0001855659 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,358 Read SEC document |
| March 10, 2025 Filed Mar 20, 2025 17:18 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantStock Option (Rt to Buy) · Derivative | 19,850 | $0.00 Strike: $10.04 | $0.00 |
DisclosureSEC source: 0001415889-25-008695 · form4-03202025_090308.xml · derivative · entry 2 Kuhn Rebecca · CIK 0001855659 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,850 Underlying: Common Stock · 19,850 shares Expires 2035-03-09 F2 · derivative.exercise_date: 25% of the shares subject to the option vest on March 3, 2026. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter. Read SEC document |
| March 10, 2025 Filed Mar 20, 2025 17:18 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantCommon Stock | 11,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008695 · form4-03202025_090308.xml · nonDerivative · entry 1 Kuhn Rebecca · CIK 0001855659 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,595 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on March 3, 2026 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 16:08 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 1,337 | $11.81 | $15,789.97 |
DisclosureSEC source: 0001415889-25-006922 · form4-03052025_090304.xml · nonDerivative · entry 1 Kuhn Rebecca · CIK 0001855659 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,895 Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 16:12 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 1,430 | $12.56 | $17,960.80 |
DisclosureSEC source: 0001415889-25-006143 · form4-03032025_090349.xml · nonDerivative · entry 1 Kuhn Rebecca · CIK 0001855659 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,232 Read SEC document |
| February 20, 2025 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 3,405 | $14.23 | $48,453.15 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 25 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,662 F1 · balance_after: Includes 12,938 shares acquired pursuant to the NeuroPace, Inc. 2021 Employee Stock Purchase Plan between April 22, 2021 and June 7, 2024. Read SEC document |
| January 22, 2025 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 265 | $14.04 | $3,720.60 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 24 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,129 Read SEC document |
| December 03, 2024 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 1,334 | $11.93 | $15,914.62 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 23 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,394 Read SEC document |
| November 20, 2024 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 3,045 | $9.19 | $27,983.55 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 22 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,728 Read SEC document |
| October 22, 2024 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 237 | $6.00 | $1,422.00 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 21 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,773 Read SEC document |
| September 03, 2024 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 1,334 | $7.39 | $9,858.26 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 20 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,010 Read SEC document |
| August 20, 2024 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 3,045 | $7.24 | $22,045.80 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 19 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,344 Read SEC document |
| July 22, 2024 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 237 | $7.65 | $1,813.05 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 18 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,389 Read SEC document |
| June 03, 2024 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 1,334 | $6.46 | $8,617.64 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 17 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,626 Read SEC document |
| May 20, 2024 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 3,045 | $7.98 | $24,299.10 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 16 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,960 Read SEC document |
| April 22, 2024 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 237 | $14.00 | $3,318.00 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 15 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,005 Read SEC document |
| March 03, 2024 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 1,042 | $15.99 | $16,661.58 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 14 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,242 Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 20:54 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantStock Option (Right to Buy) · Derivative | 24,950 | $0.00 Strike: $17.11 | $0.00 |
DisclosureSEC source: 0001209191-24-004088 · doc4.xml · derivative · entry 2 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,950 Underlying: Common Stock · 24,950 shares Expires 2034-02-26 F2 · derivative.exercise_date: 25% of the shares subject to the option vest on February 27, 2025. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter. Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 20:54 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-004088 · doc4.xml · nonDerivative · entry 1 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,204 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on February 27, 2025 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 20, 2024 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 9,832 | $17.50 | $172,060.00 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 13 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,284 Read SEC document |
| January 22, 2024 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 212 | $14.84 | $3,146.08 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 12 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,116 Read SEC document |
| December 03, 2023 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 1,010 | $8.90 | $8,989.00 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 11 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,328 Read SEC document |
| October 22, 2023 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 179 | $6.88 | $1,231.52 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 10 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,338 Read SEC document |
| September 03, 2023 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 1,010 | $8.93 | $9,019.30 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 9 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,517 Read SEC document |
| July 22, 2023 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 179 | $4.13 | $739.27 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 8 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,527 Read SEC document |
| June 03, 2023 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 1,010 | $4.11 | $4,151.10 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 7 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,706 Read SEC document |
| April 22, 2023 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 179 | $4.25 | $760.75 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 6 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,716 Read SEC document |
| March 03, 2023 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 4,019 | $4.10 | $16,477.90 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 5 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,895 Read SEC document |
| February 20, 2023 Filed Feb 22, 2023 19:53 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-011965 · doc4.xml · nonDerivative · entry 1 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,704 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on February 20, 2024 and the remaining RSUs vest in eight (8) equal quarterly installments thereafter. Read SEC document |
| January 22, 2023 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 212 | $2.98 | $631.76 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 4 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,914 Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 21:18 UTC | NeuroPace Inc NPCE · Entity 5459 | Exercise / conversionStock Option (Rt to Buy) · Derivative | 482 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001209191-22-055434 · doc4.xml · derivative · entry 6 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 482 shares Expires 2025-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The share underlying the option are fully vested. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 21:18 UTC | NeuroPace Inc NPCE · Entity 5459 | Exercise / conversionStock Option (Rt to Buy) · Derivative | 254 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001209191-22-055434 · doc4.xml · derivative · entry 5 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 254 shares Expires 2024-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The share underlying the option are fully vested. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 21:18 UTC | NeuroPace Inc NPCE · Entity 5459 | Exercise / conversionStock Option (Rt to Buy) · Derivative | 692 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001209191-22-055434 · doc4.xml · derivative · entry 4 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 692 shares Expires 2022-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The share underlying the option are fully vested. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 21:18 UTC | NeuroPace Inc NPCE · Entity 5459 | Exercise / conversionCommon Stock | 482 | $0.03 | $12.53 |
DisclosureSEC source: 0001209191-22-055434 · doc4.xml · nonDerivative · entry 3 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 21:18 UTC | NeuroPace Inc NPCE · Entity 5459 | Exercise / conversionCommon Stock | 254 | $0.03 | $6.60 |
DisclosureSEC source: 0001209191-22-055434 · doc4.xml · nonDerivative · entry 2 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,222 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 21:18 UTC | NeuroPace Inc NPCE · Entity 5459 | Exercise / conversionCommon Stock | 692 | $0.03 | $17.99 |
DisclosureSEC source: 0001209191-22-055434 · doc4.xml · nonDerivative · entry 1 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 22, 2022 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 181 | $3.02 | $546.62 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 3 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,126 Read SEC document |
| July 22, 2022 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 179 | $5.55 | $993.45 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 2 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,307 Read SEC document |
| April 22, 2022 Filed Feb 25, 2025 17:41 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 718 | $8.32 | $5,973.76 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 1 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,486 Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 20:06 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantStock Option (Right to Buy) · Derivative | 93,480 | $0.00 Strike: $8.15 | $0.00 |
DisclosureSEC source: 0001209191-22-016875 · doc4.xml · derivative · entry 2 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,480 Underlying: Common Stock · 93,480 shares Expires 2032-03-02 F2 · derivative.exercise_date: 25% of the shares subject to the option vest on March 3, 2023. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter. The option is early exercisable. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 20:06 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantCommon Stock | 46,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016875 · doc4.xml · nonDerivative · entry 1 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,276 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on March 3, 2023 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 18:03 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantStock Option (Right to Buy) · Derivative | 16,363 | $0.00 Strike: $21.67 | $0.00 |
DisclosureSEC source: 0001209191-21-038993 · doc4.xml · derivative · entry 2 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,363 Underlying: Common Stock · 16,363 shares Expires 2031-06-03 F2 · derivative.exercise_date: 25% of the shares subject to the option vest on April 22, 2022. The remaining shares subject to the option vest in twelve (12) equal quarterly installments thereafter. The option is early exercisable. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 18:03 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantCommon Stock | 8,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-038993 · doc4.xml · nonDerivative · entry 1 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,407 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on April 22, 2022 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| June 04, 2021 Filed Jun 29, 2021 18:11 UTC Amendment | NeuroPace Inc NPCE · Entity 5459 | GrantStock Option (Right to Buy) · Derivative | 16,620 | $0.00 Strike: $21.67 | $0.00 |
DisclosureSEC source: 0001209191-21-043741 · doc4a.xml · derivative · entry 2 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,620 Underlying: Common Stock · 16,620 shares Expires 2031-06-03 F2 · derivative.exercise_date: 25% of the shares subject to the option vest on April 22, 2022. The remaining shares subject to the option vest in twelve (12) equal quarterly installments thereafter. The option is early exercisable. Read SEC document |
| June 04, 2021 Filed Jun 29, 2021 18:11 UTC Amendment | NeuroPace Inc NPCE · Entity 5459 | GrantCommon Stock | 8,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-043741 · doc4a.xml · nonDerivative · entry 1 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,536 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on April 22, 2022 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.